Has James Hensarling received payments from drug or device companies?

Yes. Drug and device makers reported $7,533 in general payments to James Hensarling across 453 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Hensarling did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Hensarling come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Hensarling

Rheumatology · Flowood, MSNPI 1255334280

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 453 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Amgen at 27.0% of the total. Reporting peaked in 2019 at $2,697 and has fallen 98.6% since, to $37 in 2023. That places this record below the midpoint for rheumatology clinicians in MS, where the typical reported total is $8,210.

$7,533in general payments, 2019–2025

Across 453 payments — averaging $16.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$2K
AbbVie$2K
Pfizer$788
UCB, Inc.$692
Novartis$523
Johnson & Johnson$448
plus $2K from 13 others

$11,485in research payments, 2019–2025

Across 2 payments — averaging $5742.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Amgen$11K

What the payments were for

Food & beverage$7,514100%
Education$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen(2 entities)	115	$2,032
AbbVie	91	$1,540
Pfizer	52	$788
UCB, Inc.	53	$692
Novartis	31	$523
Johnson & Johnson	26	$448
Boehringer Ingelheim	12	$240
Regeneron Healthcare Solutions, Inc.	15	$226
Lilly USA, LLC	13	$208
Sanofi	11	$194
Mallinckrodt Hospital Products Inc.	10	$148
Janssen Scientific Affairs, LLC	2	$119
Genentech USA, Inc.	6	$103
AstraZeneca(2 entities)	3	$71
Eisai Inc.	4	$65
E.r. Squibb & Sons, L.L.C.	4	$60
GSK	2	$34
Radius Health, Inc.	2	$28
Merck	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,533 in reported general payments places this provider in the 45th percentile of 44 rheumatology providers in Mississippi.

See all rheumatology providers in Mississippi →

Other rheumatology in Flowood

Sharon HongFlowood$22K
Kenneth HardyFlowood$246
Kirk EddlemanOxford$576K
Jason TaylorMadison$173K
Vikas MajithiaJackson$123K
David WeissHattiesburg$118K
Matthew CarrollKeesler Afb$56K
Neal ShparagoJackson$39K
Seth ComptonMadison$22K
Nicole WaltonOcean Springs$19K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →